Reproductive Endocrinology Oxford Study (RepOx)
This is a prospective observational study that aims to identify the underlying mechanisms of PolyCystic Ovarian Syndrome (PCOS) and associated comorbidities such as subfertility, miscarriage; and pregnancy complications such as gestational diabetes mellitus and Intrahepatic cholestasis of pregnancy (ICP). This will be achieved through cross-sectional observation and laboratory analyses.
• ● General Criteria for all groups
‣ Participant is willing and able to give informed consent for participation in the study.
⁃ Female, aged between 16 and 45 years of age. As IVF is not undertaken in women less that 18 years, this group will between 18 and 45 years o
‣ ● PCOS (Group 1, 2 and 3)
⁃ Currently under investigation for or having diagnosis of PCOS having displayed one or more of the following: Hyperandrogenism, Ovulation Dysfunction and Polycystic ovaries on ultrasound (known as the Rotterdam criteria)
‣ ● PCOS Controls (Group 4 and 5)
⁃ Patients under gynaecological investigation or having assisted reproduction
⁃ Exhibit no features of PCOS
‣ ● Miscarriage Group (Group 6)
⁃ Have had at least two previous miscarriages
⁃ Recruited at any time after their second menstrual cycle following a miscarriage
‣ ● Miscarriage Controls (Group 7)
⁃ Patients will have had zero or no more than one miscarriage and having fertility investigations.
‣ ● Pregnant GDM (Group 8)
⁃ Pregnant women at least 28 weeks gestation with :
⁃ 1\) A fasting plasma glucose of 5.1mmol/L or above or
⁃ 2\) A 1 hr plasma glucose of 10mmol/L or
⁃ 3\) A 2-hr plasma glucose level of 8.5mmol/L or above
‣ ● Pregnant ICP (Group 9)
⁃ Women at least 28 weeks gestation with :
⁃ Raised ALT or raised bile acids in the context of pruritus with no rash
⁃ ALT (\>32iu/l) and bile acids (\>14micromol/l) Pregnant Control (Group 10)
⁃ Pregnant women at least 28 weeks gestation with no diagnosis of GDM or ICP